Monday, June 15, 2026

The $13.75 Billion Scam: Microsoft Is Accused of Blocking Competition To Keep AI Prices Sky-High

Microsoft faces a class-action lawsuit over alleged inflated ChatGPT fees due to an exclusive cloud contract with OpenAI.

U.S.-Iran Ceasefire: What 15 Key Terms Could Mean for Asian Markets?

U.S. and Iran may announce a ceasefire, boosting South Korean stocks, while market sentiment remains volatile amid ongoing conflicts.

Democrats Under Fire: What’s Their Stance on North Korea’s Russia Deployment?

The People Power Party urged the Democratic Party to clarify its stance on North Korea's troop dispatch amid rising tensions.

Tag: autoimmune diseases

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Penetrium’s Innovative Approach Could Change Cancer Treatment Forever

Penetrium Bioscience will unveil a new therapeutic mechanism for treating cancer and other diseases on April 16 in Seoul.

Imeroprubart vs. Batoclimab: Which Treatment Will Revolutionize Graves’ Disease Management?

HanAll Biopharma's Imeroprubart targets Graves' disease, showing promise with IgG suppression and user-friendly auto-injector delivery.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.